Clinical Trial Update: Tranexamic Acid Therapy For The Treatment of Subdural Hematomas [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating tranexamic acid therapy for chronic subdural hematoma. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subdural Hematoma

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Chronic Subdural Hematoma | Phase 2 | Status: NOT_YET_RECRUITING